Baillie Gifford & Co
GHDX

Baillie Gifford & Co’s Genomic Health, Inc. GHDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-548,376
Closed -$15.9M 202
2016
Q3
$15.9M Sell
548,376
-571,920
-51% -$16.5M 0.02% 130
2016
Q2
$29M Sell
1,120,296
-216,793
-16% -$5.61M 0.05% 101
2016
Q1
$33.1M Sell
1,337,089
-92,120
-6% -$2.28M 0.06% 100
2015
Q4
$50.3M Hold
1,429,209
0.09% 88
2015
Q3
$30.2M Sell
1,429,209
-141,159
-9% -$2.99M 0.06% 105
2015
Q2
$43.6M Sell
1,570,368
-318,258
-17% -$8.84M 0.08% 98
2015
Q1
$57.7M Buy
1,888,626
+40,579
+2% +$1.24M 0.11% 94
2014
Q4
$59.1M Sell
1,848,047
-16,159
-0.9% -$517K 0.12% 90
2014
Q3
$52.8M Buy
1,864,206
+470,098
+34% +$13.3M 0.12% 89
2014
Q2
$38.2M Buy
1,394,108
+56,393
+4% +$1.55M 0.08% 102
2014
Q1
$35.2M Buy
1,337,715
+184,686
+16% +$4.86M 0.08% 96
2013
Q4
$33.8M Buy
1,153,029
+317,463
+38% +$9.29M 0.08% 103
2013
Q3
$25.6M Buy
835,566
+299,656
+56% +$9.16M 0.06% 107
2013
Q2
$17M Buy
+535,910
New +$17M 0.05% 116